Bora Pharmaceuticals Co., Ltd.
Research Bora Pharmaceuticals Co., Ltd. (6472.TW) on Bullrun: market cap TWD 54.28B, P/E 29.9, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6472.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 54.28B
- P/E29.9
- Dividend yield2.5%
- Financial periodQ2 2026
- RevenueTWD 5.89B
- Net incomeTWD 555.76M
- Free cash flowTWD 347.16M
- Gross margin41.3%
Valuation Snapshot
latest market cap is TWD 54.28B; P/E is 29.9; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 29.92x versus a Healthcare sector median of 21.8x (37.3% above).
Latest dividend yield is 2.48% versus a Healthcare sector median of 2.4% (3.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 54.28B | 29.9 | 2.4% | 10 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 10 TWD, yield 2.5%.
About Bora Pharmaceuticals Co., Ltd.
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products.
ETFs that hold Bora Pharmaceuticals Co., Ltd.
US-listed ETFs
Bora Pharmaceuticals Co., Ltd. is held by 19 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | 0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | 0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.02% | 0.06% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bora Pharmaceuticals Co., Ltd.'s market cap?
Bora Pharmaceuticals Co., Ltd.'s market capitalization is TWD 54.28B.
What is Bora Pharmaceuticals Co., Ltd.'s P/E ratio?
Bora Pharmaceuticals Co., Ltd.'s price-to-earnings (P/E) ratio is 29.9.
Does Bora Pharmaceuticals Co., Ltd. pay a dividend?
Bora Pharmaceuticals Co., Ltd. has a dividend yield of 2.5%.
What does Bora Pharmaceuticals Co., Ltd. do?
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products.